Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Francese James E	2. Issuer Name and Ticker or Trading Symbol STAAR SURGICAL CO [ STAA ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Sr. VP, Comm. Ops., NA, APAC
(Last)          (First)          (Middle) 25651 ATLANTIC OCEAN DRIVE	3. Date of Earliest Transaction (MM/DD/YYYY) 5/11/2020
(Street) LAKE FOREST, CA 92630 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	5/11/2020		M		8000	A	$7.35	52466	D
Common Stock	5/11/2020		M		10856	A	$15.54	63322	D
Common Stock	5/11/2020		S		18856	D	$39.06 (1)	44466	D
Common Stock	5/13/2020		M		6667	A	$5.34	51133	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Options	$7.35	5/11/2020		M			8000	4/7/2016	4/6/2025	Common Stock	8000	$0.00	17000	D
Common Stock Options	$15.54	5/11/2020		M			10856	3/7/2015	3/6/2024	Common Stock	10856	$0.00	4144	D
Common Stock Options	$5.34	5/13/2020		M			6667	3/4/2014	3/3/2023	Common Stock	6667	$0.00	13333	D

Explanation of Responses:
(1)	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.10, inclusive.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Francese James E 25651 ATLANTIC OCEAN DRIVE LAKE FOREST, CA 92630			Sr. VP, Comm. Ops., NA, APAC

Signatures
/s/ Samuel Gesten as attorney-in-fact for James Francese		5/13/2020
**Signature of Reporting Person		Date